GlassScriptPhysician profile
Nabil Ahmad
NPI 1316908155
$20,902.23
in general payments reported to CMS, 2019-2025
59 companies · $2,365 in 2025
The $2,365 reported for 2025 was more than what 88% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,173 · 2020: $1,224 · 2021: $4,706 · 2022: $1,752 · 2023: $4,454 · 2024: $2,228 · 2025: $2,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,827 · Travel and Lodging: $1,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,826.76 |
| Travel and Lodging | $1,220.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $2,385.27 | 2021-2024 | Ha Minuteman G3-R |
| Abbvie INC. | $2,203.66 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Abbott Laboratories | $1,751.23 | 2019-2025 | Eterna, Proclaim |
| Medtronic, INC. | $1,705.52 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Vertos Medical, INC. | $1,451.15 | 2019-2021 | |
| Nalu Medical, INC. | $997.46 | 2021-2023 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $677.13 | 2019-2020 | |
| Nevro Corp. | $672.75 | 2021-2023 | Senza |
| Curonix LLC | $622.82 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $532.51 | 2019-2025 | |
| Medtronic USA, INC. | $527.30 | 2019-2020 | |
| Globus Medical, INC. | $446.49 | 2025 | Vyrsa V1, Senza |
| Spr Therapeutics, INC | $438.60 | 2022-2025 | Sprint Pns System |
| Amgen INC. | $411.44 | 2019-2022 | |
| Allergan, INC. | $399.33 | 2019-2022 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.